For this study, researchers reviewed cases of 70 patients with recurrent C. difficile who underwent fecal transplantation. Within 12 weeks after transplantation, symptoms subsided in all but four patients with 027 C. difficile infection. These four patients displayed a pre-existing serious condition and subsequently died of colitis.
In addition, four patients had an infectious relapse one year after transplantation, two of whom were treated successfully with another fecal transplantation and two of whom were treated with antibiotics. The researchers did not observe any immediate complications following the transplantations.
Related Articles on Infections:
62 Florida Hospitals Join National Initiative to Improve Safety, Readmissions Rate
IDSA Proposes New Pathway for Antibiotic Approval
Call to Action Aims to Protect Healthcare Workers From Bloodborne Diseases
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
